VTRS Down on Late-Stage Study Failure of Eye Disease Drug

• click to rate

  Posted by Two Blokes Jul 21 - Filed in Stock - 6 views
  
  VTRS slides after phase III trial failure for blepharitis drug MR-139, adding pressure to an already struggling stock.